Most Recent Articles by Britt Gambino
A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.
The FDA approved the supplemental New Drug Application for Avycaz to treat adults with hospital-acquired or ventilator-associated bacterial pneumonia.
Patients with sleep apnea may have a higher risk for recurrent stroke and death.
Patients with either central or peripheral pulmonary embolism had positive outcomes with surgical pulmonary embolectomy for peripheral distribution of thrombus.
The American Heart Association panel found that sleep disorders are associated with adverse cardiometabolic risk profiles and outcomes.